Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Endometrial Neoplasms × Aromatase Inhibitors × Clear all

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced Breast Cancer 1

Interventions

pembrolizumab 23 Paclitaxel 19 Carboplatin 17 Specimen Handling 12 Bevacizumab 11 Letrozole 10 dostarlimab 7 Magnetic Resonance Spectroscopy 7 Biopsy 7 abemaciclib 6 Taxes 6 Fulvestrant 6 Megestrol Acetate 5 Medroxyprogesterone Acetate 5 Cisplatin 5 Blood Specimen Collection 5 trastuzumab deruxtecan 4 olaparib 4 Observation 4 Immunoglobulin G 4 Drug Therapy 4 Doxorubicin 4 palbociclib 3 lenvatinib 3 atezolizumab 3 X-Rays 3 Radiotherapy 3 Progestins 3 Nivolumab 3 Gemcitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03621904 2023-01-18

PROMOTE

Radboud University Medical Center

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡